|Day's Range||40.4900 - 41.3000|
|52 Week Range||27.5300 - 43.6200|
|PE Ratio (TTM)||-80.16|
|Earnings Date||Jul 31, 2017 - Aug 4, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||41.29|
Haemonetics Corp (NYSE:HAE) files its latest 10-K with SEC for the fiscal year ended on March 31, 2017.
BRAINTREE, Mass., May 22, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that it will host an investor and analyst meeting on Monday, June 19 th from 10:00am to 2:00pm Eastern Time ...
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Haemonetics Corp. a score of 21. Our analysis is based on comparing Haemonetics Corp. with the following peers – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, C. R. Bard, Inc., Cerus Corporation, Baxter International Inc., PerkinElmer, Inc., Cytori Therapeutics, Inc., HemaCare Corporation and Johnson ... Read more (Read more...)